Nautilus Biotechnology Statistics
Total Valuation
NAUT has a market cap or net worth of $322.70 million. The enterprise value is $213.66 million.
Important Dates
The last earnings date was Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NAUT has 125.56 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Shares Outstanding | 125.56M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 32.33% |
| Owned by Institutions (%) | 20.08% |
| Float | 41.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 40.60 |
| PB Ratio | 1.44 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.65, with a Debt / Equity ratio of 0.14.
| Current Ratio | 16.65 |
| Quick Ratio | 16.23 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.04% and return on invested capital (ROIC) is -17.94%.
| Return on Equity (ROE) | -28.04% |
| Return on Assets (ROA) | -17.62% |
| Return on Capital (ROIC) | -17.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$420,419 |
| Employee Count | 167 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.45% in the last 52 weeks. The beta is 1.04, so NAUT's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -10.45% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 40.98 |
| Average Volume (20 Days) | 65,120 |
Short Selling Information
The latest short interest is 1.21 million, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 1.21M |
| Short Previous Month | 1.21M |
| Short % of Shares Out | 0.96% |
| Short % of Float | 2.88% |
| Short Ratio (days to cover) | 14.90 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -81.50M |
| Pretax Income | -69.64M |
| Net Income | -70.21M |
| EBITDA | -79.40M |
| EBIT | -81.50M |
| Earnings Per Share (EPS) | -$0.56 |
Full Income StatementBalance Sheet
The company has $140.61 million in cash and $31.57 million in debt, giving a net cash position of $109.04 million or $0.87 per share.
| Cash & Cash Equivalents | 140.61M |
| Total Debt | 31.57M |
| Net Cash | 109.04M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 223.43M |
| Book Value Per Share | 1.78 |
| Working Capital | 135.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$58.74 million and capital expenditures -$2.28 million, giving a free cash flow of -$61.02 million.
| Operating Cash Flow | -58.74M |
| Capital Expenditures | -2.28M |
| Free Cash Flow | -61.02M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |